Abbott Laboratories (ABT)
NYSE
Closed
Oct 15, 2026
Day's Range
104.0952 wk Range
81.97Overview - ABT - Abbott Laboratories
Key Statistics
Valuation
Enterprise Value
198.60B
P/E (Trailing)
‪32.08‬
P/E (Forward)
‪16.39‬
PEG Ratio
‪-0.66‬
Price / Sales (TTM)
‪3.71‬
Price / Book
‪3.36‬
EV / EBITDA
‪17.00‬
Profitability
Profit Margin
‪11.64%‬
Operating Margin
‪14.70%‬
Return on Assets
‪5.32%‬
Return on Equity
‪10.57%‬
Ownership
Shares Outstanding
1.74B
Float
1.71B
Short % of Shares Outstanding
‪1.28%‬
Held by Insiders
‪0.49%‬
Held by Institutions
‪81.79%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪106.29‬
200-Day Avg
‪103.47‬
Dividends
Payout Ratio
‪78.71%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 120.20‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABT - Abbott Laboratories
Peers - ABT - Abbott Laboratories
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - ABT - Abbott Laboratories
About
Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a broad range of medical devices, diagnostic systems, nutritional products, and branded generic medicines. Its portfolio spans cardiovascular care, diabetes management, electrophysiology, structural heart, neuromodulation,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
